Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 23 tags : Collaboration save search
LGI Homes Announces Collaboration with Modsy to Introduce New Immersive Web Experiences
Published: 2021-06-23 (Crawled : 00:00) - globenewswire.com
LGIH | $94.03 0.7% 0.69% 170K
|
Consumer Durables
|
| O: -0.55%
H: 1.38%
C: 0.97%
collaboration announces collaboration
Pacific Biosciences and Rady Children’s Institute for Genomic Medicine Announce its First Research Collaboration for Whole Genome Sequencing
Published: 2021-06-23 (Crawled : 21:00) - globenewswire.com
PACB | $1.55 0.0% 8.8M
|
Health Technology
|
| O: 0.64%
H: 4.05%
C: 2.78%
collaboration genomic children research
Now Available: Jabra PanaCast 50 video bar for insight driven collaboration in the hybrid world
Published: 2021-06-23 (Crawled : 19:00) - prnewswire.com
INTC | $34.4 0.59% 0.58% 37M
|
Electronic Technology
|
| O: 0.42%
H: 1.1%
C: 1.05%
collaboration
Hybrid Collaboration Is Hard
Published: 2021-06-23 (Crawled : 13:15) - steelcase.com
SCS | $12.18 2.01% 0.0% 500K
|
Producer Manufacturing
|
| O: 0.62%
H: 1.3%
C: -0.14%
collaboration
Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery
Published: 2021-06-23 (Crawled : 13:00) - prnewswire.com
RXRX | $7.605 3.47% 3.35% 3.8M
|
Professional, Scientific, and T...
|
| O: 0.48%
H: 2.56%
C: -6.61%
collaboration drug discovery drug multi-year
Sosei Heptares Initiates Phase 1 Trial With Novel Small-Molecule CGRP Antagonist Under Collaboration With Biohaven
Published: 2021-06-23 (Crawled : 07:00) - prnewswire.com
BHVN | News 0 d | $38.33 -1.69% -0.03% 1.1M
|
Health Technology
|
| O: 0.29%
H: 1.88%
C: 0.25%
phase 1 collaboration trial phase 2 phase 3
Tiziana Enters a Collaboration Agreement with FHI Clinical to Conduct a Phase 2 Clinical Trial for Treating Hospitalized Severe COVID-19 Patients with Intranasal Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody
Published: 2021-06-23 (Crawled : 07:00) - globenewswire.com
TLSA | News | $0.75 12.61% 11.2% 540K
|
Health Technology
|
| O: 7.83%
H: 3.63%
C: -2.82%
covid phase 2 foralumab collaboration antibody trial
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.